Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1136781

	registered interest
	date	03/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Academic Health Science Networks
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government by what process, during the current development of policy options for Academic Health Science Centres (AHSC), potential new AHSCs can be considered in areas of England currently unrepresented by existing AHSCs.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL16931
	answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country’s health research and innovation ecosystem.</p><p>The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.</p><p>The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.</p><p>It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.</p><p>The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department’s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.</p><p>As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.</p><p>As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:</p><p>- The King’s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;</p><p>- University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;</p><p>- The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and</p><p>- The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL16932 HL16934 question first answered 17/07/2019 16:29:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1136782

	registered interest
	date	03/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what the future relationship will be between Academic Health Science Networks, Academic Health Science Centres and Academic Research Collaborations with regard to the future applied health science ecosystem.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL16932
	answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country’s health research and innovation ecosystem.</p><p>The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.</p><p>The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.</p><p>It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.</p><p>The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department’s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.</p><p>As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.</p><p>As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:</p><p>- The King’s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;</p><p>- University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;</p><p>- The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and</p><p>- The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL16931 HL16934 question first answered 17/07/2019 16:29:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1136784

	registered interest
	date	03/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Academic Health Science Networks
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of whether the innovations arising from the current phase of Academic Health Science Centres are being made available to patients throughout the NHS.
	tabling member printed	Lord Willis of Knaresborough
	uin	HL16934
	answer	answer is ministerial correction date of answer 17/07/2019 answer text <p>The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country’s health research and innovation ecosystem.</p><p>The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.</p><p>The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.</p><p>It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.</p><p>The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department’s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.</p><p>As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.</p><p>As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:</p><p>- The King’s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;</p><p>- University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;</p><p>- The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and</p><p>- The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL16931 HL16932 question first answered 17/07/2019 16:29:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4151 label Biography information for Lord Willis of Knaresborough

1137406

	registered interest
	date	08/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Shingles: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to establish a GP-operated call/recall system to invite older people to receive the shingles vaccination.
	tabling member printed	Baroness Walmsley
	uin	HL17013
	answer	answer is ministerial correction date of answer 19/07/2019 answer text <p>As outlined in both the NHS Long Term Plan and <em>Investment and evolution: a five-year framework for GP contract reform to implement The NHS Long Term Plan</em>, NHS England and NHS Improvement are currently undertaking a Review of vaccinations and immunisations. The Department would not wish to pre-empt the outcome of this Review. <em>Investment and evolution</em> sets out the purpose of the Review as being to:</p><p>- Ensure the system incentivises achievement of appropriate uptake rates for immunisations in line with national public health uptake rates;</p><p>- Reduce the administrative burden on general practices by simplifying the system if possible;</p><p>- Clarify what is expected on call/recall for immunisations delivered through the general practitioner (GP) contract;</p><p>- Address anomalies in the system that directly incentivise some vaccines but not others;</p><p>- Look at how we deal with outbreaks and catch-up programmes; and</p><p>- Consider whether we extend the list of chargeable travel vaccines.</p><p>Recommendations from the Review will be implemented through the 2020 and 2021 GP contracts.</p><p>A copy of <em>Investment and evolution: a five-year framework for GP contract reform to implement The NHS Long Term Plan</em> is attached.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 19/07/2019 09:14:02 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name gp-contract-2019.pdf title Five Year framework for GP contract reform
	tabling member	2547 label Biography information for Baroness Walmsley

1137409

	registered interest
	date	08/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Death
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the report by the Royal College of Physicians The National Review of Asthma Deaths, published on 6 May 2014; and what plans they have to implement that report's recommendations.
	tabling member printed	Baroness Wheeler
	uin	HL17016
	answer	answer is ministerial correction date of answer 19/07/2019 answer text <p>The Department collaborated with the Royal College of Physicians on the National Review of Asthma Deaths and welcomed this report. Since its publication, significant improvements have been made in asthma care.</p><p> </p><p>Respiratory disease, including asthma, is a clinical priority within the NHS Long Term Plan, which aims to improve outcomes for patients through earlier diagnosis and increased access to treatments. The Respiratory Delivery Board will take forward respiratory proposals set out in the Plan by working with key partners.</p><p> </p><p>The National Health Service is supporting the national asthma audit programme which provides data on a range of indicators to show improvements and opportunities in asthma outcomes. NHS RightCare will be publishing an asthma toolkit later this year to support local commissioners and systems in delivering quality care. A best practice tariff for asthma, which aims to reduce variation in asthma care, is also in development.</p><p> </p><p>The current quality outcomes framework indicators for asthma are in consultation and changes for the annual review indicators may include data on asthma control; exacerbations; and written personalised action plans.</p><p> </p><p>As set out in the Long Term Plan, pharmacies in primary care networks will undertake medicine reviews for asthma patients. This will include education on inhaler use and uptake of dry powder and smart inhalers where clinically appropriate.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 19/07/2019 09:14:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	4157 label Biography information for Baroness Wheeler

1137944

	registered interest
	date	09/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Data Protection: USA
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to design a new, improved data privacy shield that takes on board concerns about the current EU–United States Privacy Shield before negotiating a trade deal with the government of the United States after Brexit, so that it safeguards individuals as well as providing for the promotion of the UK’s life science and technology sectors.
	tabling member printed	Lord Freyberg
	uin	HL17043
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>The Government has committed to maintaining a high level of data protection standards, which are set out in the Data Protection Act 2018.</p><p>These safeguards allow the public to have trust in how and why their data is used and it is important that we maintain them. Access and use of data should always be done lawfully, safely and securely. We reiterate that National Health Service data must always be held securely, with appropriate and strong privacy and cyber-security protections.</p><p>As the United Kingdom leaves the European Union we have made arrangements with the United States that will ensure that in both ‘deal’ and ‘no deal’ scenarios, transfers of personal data from the UK to US Privacy Shield participant organisations can continue to be made under the Privacy Shield Framework.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17044 question first answered 23/07/2019 15:33:07 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2593 label Biography information for Lord Freyberg

1137945

	registered interest
	date	09/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services and Social Services: Data Protection
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to explore the scope to design a dedicated privacy shield confined to health and care data before negotiating a trade deal with the government of the United States after Brexit.
	tabling member printed	Lord Freyberg
	uin	HL17044
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>The Government has committed to maintaining a high level of data protection standards, which are set out in the Data Protection Act 2018.</p><p>These safeguards allow the public to have trust in how and why their data is used and it is important that we maintain them. Access and use of data should always be done lawfully, safely and securely. We reiterate that National Health Service data must always be held securely, with appropriate and strong privacy and cyber-security protections.</p><p>As the United Kingdom leaves the European Union we have made arrangements with the United States that will ensure that in both ‘deal’ and ‘no deal’ scenarios, transfers of personal data from the UK to US Privacy Shield participant organisations can continue to be made under the Privacy Shield Framework.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17043 question first answered 23/07/2019 15:33:07 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	2593 label Biography information for Lord Freyberg